Rafferty Asset Management’s Blueprint Medicines BPMC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$7.76M Sell
60,567
-38,753
-39% -$4.97M 0.03% 318
2025
Q1
$8.79M Buy
99,320
+10,429
+12% +$923K 0.04% 279
2024
Q4
$7.75M Sell
88,891
-28,133
-24% -$2.45M 0.03% 327
2024
Q3
$10.8M Buy
117,024
+22,061
+23% +$2.04M 0.04% 275
2024
Q2
$10.2M Sell
94,963
-4,388
-4% -$473K 0.04% 276
2024
Q1
$9.42M Sell
99,351
-22,017
-18% -$2.09M 0.04% 283
2023
Q4
$11.2M Sell
121,368
-45,322
-27% -$4.18M 0.05% 241
2023
Q3
$8.37M Buy
166,690
+24,693
+17% +$1.24M 0.05% 270
2023
Q2
$8.97M Sell
141,997
-19,893
-12% -$1.26M 0.05% 230
2023
Q1
$7.28M Sell
161,890
-8,792
-5% -$396K 0.05% 278
2022
Q4
$7.48M Buy
170,682
+79,592
+87% +$3.49M 0.06% 280
2022
Q3
$6M Buy
91,090
+11,687
+15% +$770K 0.06% 292
2022
Q2
$4.01M Sell
79,403
-14,232
-15% -$719K 0.04% 327
2022
Q1
$5.98M Buy
93,635
+39,214
+72% +$2.5M 0.04% 331
2021
Q4
$5.83M Buy
54,421
+22,836
+72% +$2.45M 0.03% 318
2021
Q3
$3.25M Buy
31,585
+1,571
+5% +$162K 0.02% 430
2021
Q2
$2.64M Sell
30,014
-1,033
-3% -$90.9K 0.02% 560
2021
Q1
$3.02M Buy
31,047
+22,919
+282% +$2.23M 0.02% 489
2020
Q4
$912K Sell
8,128
-21,730
-73% -$2.44M 0.01% 529
2020
Q3
$2.77M Buy
29,858
+16,194
+119% +$1.5M 0.03% 331
2020
Q2
$1.07M Buy
13,664
+8,309
+155% +$648K 0.02% 524
2020
Q1
$313K Sell
5,355
-40,170
-88% -$2.35M 0.01% 426
2019
Q4
$3.65M Sell
45,525
-36,595
-45% -$2.93M 0.06% 188
2019
Q3
$6.03M Buy
82,120
+27,608
+51% +$2.03M 0.09% 126
2019
Q2
$5.14M Buy
54,512
+18,182
+50% +$1.72M 0.09% 158
2019
Q1
$2.91M Buy
+36,330
New +$2.91M 0.05% 226